Golu, M.V.; Pașcanu, I.; Togănel, C.; Petrovan, C.; Cosarcă, A.; Bereczki Temistocle, D.L.; Ormenișan, A.
What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough? Appl. Sci. 2022, 12, 9224.
https://doi.org/10.3390/app12189224
AMA Style
Golu MV, Pașcanu I, Togănel C, Petrovan C, Cosarcă A, Bereczki Temistocle DL, Ormenișan A.
What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough? Applied Sciences. 2022; 12(18):9224.
https://doi.org/10.3390/app12189224
Chicago/Turabian Style
Golu, Mihai Vlad, Ionela Pașcanu, Cornelia Togănel, Cecilia Petrovan, Adina Cosarcă, Despina Luciana Bereczki Temistocle, and Alina Ormenișan.
2022. "What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?" Applied Sciences 12, no. 18: 9224.
https://doi.org/10.3390/app12189224
APA Style
Golu, M. V., Pașcanu, I., Togănel, C., Petrovan, C., Cosarcă, A., Bereczki Temistocle, D. L., & Ormenișan, A.
(2022). What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough? Applied Sciences, 12(18), 9224.
https://doi.org/10.3390/app12189224